Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

4.45
Delayed Data
As of Mar 22
 +0.15 / +3.49%
Today’s Change
2.40
Today|||52-Week Range
10.98
+41.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$92.8M

Company Description

Adamis Pharmaceuticals Corp. is a pharmaceutical company engages in the provision of medical development. Its activities include the combination of specialty pharmaceuticals and biotechnology to produce medicines for patients, and physicians. It focuses on products such as inhaler technology in the field of allergy and respiratory diseases. The company was founded on April 1, 2009 and is headquartered in San Diego, CA.

Contact Information

Adamis Pharmaceuticals Corp.
11682 El Camino Real
San Diego California 92130
P:(858) 997-2400
Investor Relations:
(858) 412-7951

Employees

Shareholders

Other institutional8.90%
Mutual fund holders4.16%
Individual stakeholders16.16%

Top Executives

Dennis J. CarloPresident, Chief Executive Officer & Director
Karen K. DanielsVice President-Operations
Robert O. HopkinsChief Financial Officer, Secretary & VP-Finance
Thomas H. MollVice President-Research
David J. MarguglioDirector & Senior VP-Corporate Development